Christopher Dobson

Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases.

Researchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease.

The Chemistry of Health building, a new facility dedicated to the use of chemical techniques to combat disease, in particular neurodegenerative...

Leaders in fields from classics to Alzheimer’s research are recognised today in the Queen's Birthday Honours list.

Researchers have shown how cholesterol – a molecule normally linked with cardiovascular diseases – may also play an important role in the onset and...

Gifts totalling more than £32 million, together with government funds of over £17 million, have enabled the launch of a highly innovative Centre in...

New funding will support fundamental research into the molecular processes underlying human disorders such as Alzheimer’s and Parkinson’s diseases...